Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Pharma Trump selects surgeon and author Martin Makary for FD

<< Previous

Bullboard Posts

Next >>

Comment by Sosak1on Dec 12, 2024 1:57pm

148 Views

Post# 36359424

RE:Pharma Trump selects surgeon and author Martin Makary for FD

I like this statment Martin Makary is likely to have a "more reasonable approach to running the FDA than has been feared," adding that the nominee "appears well-versed across the continuum of U.S. healthcare and is supportive of evidence-based medical intervention."

<< Previous

Bullboard Posts

Next >>

Invest wiser with BMO's InvestorLine Platform features